Neutrophil-specific granule deficiency is a disorder of leukocyte maturation associated with decreased levels of mRNA for a distinct subset of granule proteins. Our work indicates that this disorder, previously thought to be limited to the neutrophil lineage, can also include eosinophils. Immunofluorescence staining led to the discovery of a small but distinct population of peripheral white blood cells containing eosinophil peroxidase (EPO). Unlike normal eosinophils, these EPO+ cells do not have large, eosin-staining cytoplasmic granules, and are indistinguishable from granule-deficient neutrophils by light microscopy. The EPO+ cell lineage did resemble the normal eosinophil lin-EUTROPHIL-SPECIFIC granule deficiency is a rare N disorder in which an increased susceptibility to bacterial infection is coupled to specific defects in neutrophil structure and function. Defects in neutrophil chemotaxis, disaggregation, receptor upregulation, and bactericidal activity',* are found in conjunction with specific structural abnormalities. These abnormalities include large, cleft nuclei and the absence of secondary or specific cytoplasmic granules. Only trace amounts of lactofemn, vitamin B-12 binding protein, and collagenase, all specific granule proteins, are detected in peripheral blood neutrophils from affected individuals.' Reduced levels of the primary granule proteins, defensins, have also been r e p~r t e d .~ Lomax et a14 showed that only trace quantities of lactofenin mRNA could be detected in bone marrow from an individual with specific granule deficiency. Although lactofemn could not be detected in granule-deficient peripheral neutrophils, nasal secretions from the same individual contained normal amounts of this protein. These findings suggested that the granule protein deficiencies were the result of a neutrophilspecific transcription defect. The experiments described in this report indicate that specific granule deficiency is not limited to neutrophils and suggest that granule protein biosynthesis in the neutrophil and eosinophil lineages may be regulated via a common mechanism.
eage in its ability to respond dramatically to granulocytemacrophage colony-stimulating factor (GM-CSF); the size of the EPO+ peripheral cell population increased -70-fold over baseline in response to GM-CSF administration. The EPO+ cells contained eosinophil Charcot-Leyden crystal protein, but were deficient in three eosinophil-specific granule proteins; neither eosinophil cationic protein, eosinophil-derived neurotoxin, nor major basic protein could be detected in these EPO+ cells, despite the presence of mRNA transcripts for each of the three absent proteins. This is a US government work. There are no restrictions on its use. The WBCs were washed twice and either frozen at -80°C or resuspended in phosphate-buffered saline (PBS) with 1% bovine Serum albumin (BSA) and fixed on glass slides via a Shandon Cytospin 2 centrifuge (Shandon, Inc, Pittsburgh, PA) (1,000 rpm for 6 minutes), followed by immersion in methanol for 5 minutes at room temperature.
Peripheral WBCs fixed on slides were hydrated for 10 minutes at room temperature in PBS and incubated with a 1.4 dilution (all dilutions in PBS) of normal goat serum (Jackson lmmunoresearch Laboratories, Inc, West Grove, PA) in a humidified chamber at 37°C for 1 hour. Slides were washed three times with PBS and then incubated as above with primary antibody ( Detection of genomic DNA sequences. Normal and specific granule-deficient peripheral leukocytes prepared and frozen as described above were resuspended at 5,00O/pL in IO mmol/L Tris-HC1/50 mmol/L KC1/2.5 mmol/L MgCI,/O.S% Tween 20 (pH 8.3) with 100 pg/pL proteinase K (Sigma Chemical Co, St Louis, MO).' Cells were incubated for I hour at 56°C and then for 10 minutes at 95°C. Polymerase chain reaction (PCR) was performed using IO pL of this digest as a template and I pmol/L primers (see below) in a final volume of 100 pL; three-temperature PCR (95°C for 20 seconds, 55°C for 20 seconds, and 72°C for 30 seconds for 40 cycles, with 3 minutes at 72°C for extension) was performed using standard reagents (GeneAmp; Perkin-Elmer Cetus, Emeryville, CA) in a Perkin-Elmer Cetus 9600 thermocycler. Ten microliters of reaction products was evaluated by agarose gel electrophoresis; ethidium-stained bands were transferred to a nitrocellulose membrane and hybridized sequentially to each of three 5'-P32-labeled gene-spe- Detection q f m R N A rranscripts. Transcripts for the individual granule proteins were detected using reverse-transcriptase PCR. One microgram of total bone marrow RNA from the individual with specific granule deficiency was transcribed to cDNA as per manufacturer's protocol (cDNA synthesis kit: Boehringer Mannheim, Indianapolis, IN) in a final volume of 100 pL. Five microliters of the cDNA solution (or buffer control) was used as a template for PCR as described above, using the gene-specific primers listed below. Amplification primers for MBP, EDN, and ECP were selected to encompass two or more exons, enabling us to differentiate between products amplified from cDNA and any that might have arisen from trace genomic contamination: the gene structure of CLC has not been reported. Products were evaluated by agarose gel electrophoresis as described above. Fig I is a comparison of peripheral WBCs from a normal donor with those from an individual with specific granule deficiency. The normal eosinophils (Fig IC and D) have bilobed nuclei and prominent cytoplasmic granules. The mouse MoAb 263ASC, specific for EPO, detects this protein in normal eosinophils (Fig IC) . The MoAb 263ASC recognizes an epitope unique to EPO; despite 68% sequence homology between EPO and neutrophil myeloperoxidase (MPO),12.'3 the neutrophils in this field remain unstained.
RESULTS
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The eosinophils from an individual with specific granule deficiency were identified by their reactivity with MoAb 263ASC (Fig 1 A) . These EPO' cells do not have prominent cytoplasmic granules (Fig I B. cell at arrow): both EPO' and EPO-granulocytes have atypically large, cleft nuclei and are otherwise indistinguishable from one another at the light microscopic level. The EPO' cells represent less than 1% of this patient's baseline total WBC count (Fig 2) .
Administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) resulted in an -70-fold expansion of the peripheral EPO' cell population (Fig 2) . At day 0, the total WBC count was 5,7OO/pL, including 0.2% EPO' cells. At day 6, the WBC count increased slightly (7,8OO/pL), whereas the pool of peripheral EPO' cells had expanded to 10% of the total, or from 1 1 to 780 EPO' cells/pL. Peripheral eosinophilia is a common reaction to GM-CSF therapy in individuals with disorders unrelated to specific granule defi~iency'~ and can occur without a concomitant neutrophilia." Proliferation in response to GM-CSF is a characteristic common to the granule-deficient EPO' cells and normal eosinophils. No morphologic changes were observed at the light microscopic level in either the EPO' or EPO-granulocyte lineages in response to GM-CSF administration.
In addition to EPO, the eosinophil-specific granule contains three other distinct proteins: MBP, ECP, and EDN. 
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-0 Shown in Fig 5 are the results from experiments in which the WBCs are double-stained with MoAb 263ASC anti-EPO and polyclonal rabbit antisera specific for the eosinophil CLC protein. a constituent of crystalloid-free eosinophil granules'* that can be distinguished from the crystalloid-containing eosinophil-specific granules. In contrast to the specific granule protein deficiencies shown for the EPO' cells, both normal eosinophils and specific granuledeficient EPO+ cells contain detectable levels of CLC protein (Fig 5B and D) .
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Although MBP, EDN, and ECPwere not found in peripheral EPO' cells, gene sequences for all three absent proteins were detected in genomic DNA isolated from granule-deficient WBCs. Gene-specific primers were used to amplify segments ofgenomic DNA encoding these proteins (see Materials and Methods and Fig 6E) . Amplification products obtained using genomic DNA from granuledeficient WBCs as a template were of appropriate,size and identical to that produced from DNA from normal WBCs for each of the three genes (Fig ~IA) .~.' In addition, each amplification product hybridized uniquely to gene-specific oligonucleotides derived from nucleotide sequence spanned by the amplification reaction (Fig 6B through D) .
Using reverse-transcriptase PCR, mRNA transcripts for MBP, EDN. ECP. and CLC were detected in total bone marrow RNA from the individual with specific granule deficiency (Fig 7) . Amplification products from each pair of gene-specific primers were of appropriate size: MBP at 668 bp, EDN at 43 I bp. CLC at 429 bp, and ECP at 2 16 bp8-" (see Materials and Methods). In addition, each product contained characteristic restriction sites and hybridized to genespecific oligonucleotides (data not shown).
DISCUSSION
Although neutrophil-specific granule deficiency is an extremely rare disorder ofleukocyte m a t u r a t i~n , '~*~~-~~e v a l u ation of this disease will add much to our understanding of granule protein regulation and biosynthesis. Previous work suggested that specific granule deficiency was the result of a neutrophil-specific transcription defect: Lomax et a14 -ecp showed that, despite the absence of lactoferrin in granuledeficient neutrophils and the detection of only trace amounts of mRNA for lactoferrin in specific granule deficiency bone marrow. there were normal levels of lactoferrin in nasal secretions. We have shown here that granule protein abnormalities similar to those reported in neutrophils are found in eosinophils. Although there were no peripheral leukocytes with characteristic eosin or fast green-staining granules. there was a small subset of peripheral WRCs that contained eosinophil peroxidase and that increased in number in response to GM-CSF administration. It is interesting to note that another individual with specific granule dcficiency initially reported by Strauss et al" was rcportcd to have a normal eosinophil count and normal eosinophil granules: furthermore. this other individual's granule-deficient neutrophils had remnants of spccific granule membrane~."'~'~ whereas none were observed in the individual described in this report." Thisdiversity ofpresentation suggests that the specific granule-deficient phenotype may result from two or more independent genetic lesions.
Although the specific granule-deficient eosinophils contained EPO and CLC. no EDN. MRP. or ECP could bc detected. There are no published reports of this eosinophil phenotype occurring elsewhere, either as an isolated condition or in conjunction with another developmental abnormality. It is interesting to compare this phenotype with that of congenital EPO deficiency. an otherwise bcnign clinical condition in which EPO is mising from the eosinophil-spccific granule.'6 It is not clear as to whether EPO deficiency represents a defect in primary peroxidasc gene structure or an aberrancy at the transcriptional or translational level. The specific granule-deficient phenotype also includes abnormalities of neutrophil primary granules. Gallin et a!' showed that neutrophil primary granules from a patient with specific granule deficiency were significantly less dense than their normal counterparts. and Parmley et showed that the neutrophil primary granules from another affected individual retained immature staining characteristics. Defensins, major components of the neutrophil primary granule. were detected at significantly reduced levels in neutrophils from two affected patients.' The defect resulting in specific granule deficiency may be manifest during a period ofgranulocyte maturation in which the synthesisofprimary and specific granule proteins overlaps.
Cells from other myeloid lineages also show evidence of granule protein deficiency. Parker et a!" have described in this individual a partial deficiency of platelet von Willebrand factor. a component of the platelet (Y granule. It is not clear at this point whether the abnormalities described for eosinophils result from a defect in transcription, as has been shown for the neutrophil l i n e a g~.~ Although we are able to detect mRNA transcripts for the three absent granule proteins. we do not know whether these transcripts are present in the bone marrow at normal or at reduced concentrations.
The data presented indicate that specific granule deficiency is a disorder that involves the dccreascd production of numerous granule proteins in at least three distinct myeloid lineages. Delineation of the specific genetic abnormality will certainly provide information on the fundamental mechanism of granule protein biosynthesis.
